You are currently viewing a new version of our website. To view the old version click .

Novel Insights into RAS-ERK Signaling Pathways in Pediatric Malignancies

This special issue belongs to the section “Cellular Pathology“.

Special Issue Information

Dear Colleagues,

We are excited to have the opportunity to organize a Special Issue dedicated to novel insights into RAS-ERK signaling pathways in pediatric malignancies in the journal Cells (impact factor 7.67). This Special Issue will highlight the most recent research conducted in the field of ERK signaling and will emphasize basic original science, as well as invited review articles.

We would like to invite you to submit either an original research or review article to this Special Issue, in recognition of your contribution to the field. Our primary focus in this edition will be RAS and ERK signaling pathways, biologic insights, targeted therapy applications, and clinical trial results in pediatric solid tumors and hematologic malignancies.  This Special Issue will also focus on genomic methods being developed and applied to advance our understanding of these tumors and the application of potential therapeutic strategies. We aim to emphasize how genomic knowledge can translate to advances in the management of patients affected by these tumors.

Dr. Christine A. Pratilas
Dr. Angelina V. Vaseva
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • ERK signaling
  • targeted therapy
  • pediatric solid tumor

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cells - ISSN 2073-4409